Wells Fargo Initiates Immunomedics At Outperform

Analysts at Wells Fargo initiated coverage on shares of Immunomedics Inc. IMMU with a Outperform rating. Immunomedics shares have dropped 3.88% over the past 52 weeks, while the S&P 500 index has gained 8.99% in the same period. Immunomedics' shares closed at $4.71 yesterday.